Reference range, target level, or decision threshold
12-16 sLD !
INR: 2.0-3.0 – target range for most patients treated with vitamin K antagonistsLD !
Interpretation of results
↑ Congenital or acquired deficiencies of fibrinogen and/or factors II, V, VII, or X due to vitamin K deficiency or treatment with vitamin K antagonists, liver disease, disseminated intravascular coagulation, hemodilution, anticoagulant interference (eg, direct thrombin or factor Xa inhibitors), high levels of unfractionated heparin